Page 116 - 《中国药房》2023年16期

化学进展，2011，23（8）：1747-1754. ticles[J]. Food Bioprod Process，2016，99：128-135.
[ 3 ] FAN K L，JIA X H，ZHOU M，et al. Ferritin nanocarrier [17] HOU Y Y，LIU R，HONG X Y，et al. Engineering a sus‐
traverses the blood brain barrier and kills glioma[J]. ACS tained release vaccine with a pathogen-mimicking manner
Nano，2018，12（5）：4105-4115. for robust and durable immune responses[J]. J Control Re‐
[ 4 ] COLLINS S M，BROWN A C. Bacterial outer membrane lease，2021，333：162-175.
vesicles as antibiotic delivery vehicles[J]. Front Immunol， [18] AOUADI M，TESZ G J，NICOLORO S M，et al. Orally
2021，12：733064. delivered siRNA targeting macrophage MAP4K4 sup‐
[ 5 ] LI W Q，WANG H M，XU X G，et al. Simultaneous na‐ presses systemic inflammation[J]. Nature，2009，458
noscale imaging of chemical and architectural heteroge- （7242）：1180-1184.
neity on yeast cell wall particles[J]. Langmuir，2020，36 [19] SALARI R，BAZZAZ B S，RAJABI O，et al. New aspects
（22）：6169-6177. of Saccharomyces cerevisiae as a novel carrier for berbe-
[ 6 ] BERNARDI B，WENDLAND J. Homologous recombina‐ rine[J]. Daru，2013，21（1）：73.
tion：a GRAS yeast genome editing tool[J]. Fermentation， [20] MIRZA Z，SOTO E R，HU Y，et al. Anthelmintic activity
2020，6（2）：57. of yeast particle-encapsulated terpenes[J]. Molecules，
[ 7 ] ÇELIK E，ÇALıK P. Production of recombinant proteins 2020，25（13）：2958.
by yeast cells[J]. Biotechnol Adv，2012，30（5）：1108- [21] SUN Y，DUAN B C，CHEN H H，et al. A novel strategy
1118. for treating inflammatory bowel disease by targeting deli-
[ 8 ] COHEN J L，SHEN Y F，AOUADI M，et al. Peptide- and very of methotrexate through glucan particles[J]. Adv
amine-modified glucan particles for the delivery of thera‐ Healthc Mater，2020，9（6）：e1901805.
peutic siRNA[J]. Mol Pharm，2016，13（3）：964-978. [22] SOTO E R，CARAS A C，KUT L C，et al. Glucan particles
[ 9 ] 邵强，黄友解，韩月，等. 酵母细胞壁的结构组成、生物学 for macrophage targeted delivery of nanoparticles[J]. J
功能及在养殖业中的应用[J]. 浙江畜牧兽医，2017，42 Drug Deliv，2012，2012：143524.
（1）：13-16. [23] SHI Q，ZHANG L，LIU M Y，et al. Reversion of multi‐
[10] BROWN G D，HERRE J，WILLIAMS D L，et al. Dectin- drug resistance by a pH-responsive cyclodextrin-derived
1 mediates the biological effects of beta-glucans[J]. J Exp nanomedicine in drug resistant cancer cells[J]. Biomate-
Med，2003，197（9）：1119-1124. rials，2015，67：169-182.
[11] 宿凡，管培竹，杨金波，等 . β-葡聚糖与识别模式受体 [24] SABU C，RAGHAV D，JIJITH U S，et al. Bioinspired oral
dectin-1 相互作用研究进展[J]. 中国海洋药物，2019，38 insulin delivery system using yeast microcapsules[J]. Ma‐
（5）：54-60. ter Sci Eng C Mater Biol Appl，2019，103：109753.
[12] CABIB E，ARROYO J. How carbohydrates sculpt cells： [25] LELOUARD H，HENRI S，BOVIS B D，et al. Pathogenic
chemical control of morphogenesis in the yeast cell wall bacteria and dead cells are internalized by a unique subset
[J]. Nat Rev Microbiol，2013，11（9）：648-655. of Peyer’s patch dendritic cells that express lysozyme[J].
[13] TAN Y F，CHEN L W，LI K，et al. Yeast as carrier for Gastroenterology，2010，138（1）：173-184.e1-3.
drug delivery and vaccine construction[J]. J Control Re‐ [26] WILLMENT J A，GORDON S，BROWN G D. Characte-
lease，2022，346：358-379. rization of the human beta-glucan receptor and its alterna‐
[14] AGUILAR-USCANGA B，FRANÇOIS J M. A study of tively spliced isoforms[J]. J Biol Chem，2001，276（47）：
the yeast cell wall composition and structure in response 43818-43823.
to growth conditions and mode of cultivation[J]. Lett Appl [27] ROGERS N C，SLACK E C，EDWARDS A D，et al. Syk-
Microbiol，2003，37（3）：268-274. dependent cytokine induction by dectin-1 reveals a novel
[15] UPADHYAY T K，FATIMA N，SHARMA D，et al. Prepa‐ pattern recognition pathway for C type lectins[J]. Immu‐
ration and characterization of beta-glucan particles con‐ nity，2005，22（4）：507-517.
taining a payload of nanoembedded rifabutin for enhanced [28] GOODRIDGE H S，REYES C N，BECKER C A，et al. Ac‐
targeted delivery to macrophages[J]. EXCLI J，2017，16： tivation of the innate immune receptor dectin-1 upon for‐
210-228. mation of a “phagocytic synapse”[J]. Nature，2011，472
[16] SALOŇ I，HANUŠ J，ULBRICH P，et al. Suspension sta‐ （7344）：471-475.
bility and diffusion properties of yeast glucan micropar‐ [29] CHAN G C F，CHAN W K，SZE D M Y. The effects of

· 2026 · China Pharmacy 2023 Vol. 34 No. 16 中国药房 2023年第34卷第16期